Outcomes Data Reveal Significant Impact of Etiometry Utilization in Liberating Patients from Invasive ICU Treatments
Studies presented at World Congress of Pediatric Cardiology and Cardiac Surgery show Etiometry’s clinical intelligence platform supports efficient escalation and safe de-escalation decisions to enhance patient outcomes and reduce length of stay BOSTON, Mass. – Aug. 28, 2023 – Etiometry, the leader in clinical decision-support software, shares exciting new study results from ten hospitals, including Boston Children’s […]
Read More
Etiometry Bolsters Data Security by Achieving SOC 2 Compliance
SOC 2 attestation underscores Etiometry’s commitment to robust data protection mechanisms for its hospital customers pursuing cloud technologies
Read More
Etiometry Gains FDA Clearance of AI-Based Algorithm that Alerts Risk of Hypercapnia for Neonates in Critical Care
Etiometry’s IVCO2 Index™ is now available for continuous non-invasive NICU ventilation monitoring for optimal outcomes without additional devices BOSTON, Mass. – Aug. 1, 2023 – Etiometry, the leader in clinical decision-support software, announced today its IVCO2 Index™ was cleared by the Food and Drug Administration for use with neonatal ICU patients under 2kg, who are especially vulnerable to […]
Read More
Etiometry Announces CE Mark and Health Canada Authorization for Adult Use of AI-Based Algorithm that Detects Risk of Hypercapnia
Previously authorized for pediatric populations, critical care teams in Europe and Canada can now utilize Etiometry’s IVCO2 IndexTM to determine the likelihood of inadequate carbon dioxide ventilation in adults BOSTON, Mass. – March 21, 2023 – Etiometry, the leader in clinical decision-support software for critical care, today announced CE Mark and Health Canada authorization of its IVCO2 […]
Read More
After Record Growth in 2022, Etiometry Paves Way for 2023 Expansion
150+ million hours of data signals, regulatory approvals key to Etiometry’s upward trajectory BOSTON, Mass. – January 31, 2023 – Etiometry, the leader in clinical decision-support software for critical care, today provided a glimpse into its 2023 priorities as well as highlights from 2022, which marked a landmark year of growth for the company – including […]
Read More
Etiometry is the First to Achieve FDA Clearance of an AI-Based Risk Algorithm that Alerts for Inadequate Oxygenation of Adult Patients in Critical Care
U.S. Hospitals can now equip clinicians in adult ICUs with Etiometry’s IDO2 Index™ to rapidly identify changes to patients’ condition. BOSTON, Mass. – January 24, 2023 – Etiometry, a leader in clinical decision-support software, announced today its IDO2 Index™ was cleared for adult use by the Food and Drug Administration. Now, U.S. hospitals can arm adult […]
Read More